Case Study: Treating Infants for Cannabis Exposure
As more and more states legalize recreational marijuana, caregivers need to be
vigilant about keeping products out of the reach of children.
Oral Treatment Approved for Anemia Caused by CKD
Daprodustat increases erythropoietin production, leading to an increase in the production of red blood cells.
A Return to Normalcy
Despite a massive COVID-19 vaccination campaign, many still fear a
return to normal.
Oncology Pharmacists Are Crucial in Skin Cancer Management
From explaining how medications work and should be taken to reviewing potential adverse effects and financial details, pharmacists are crucial resources for patients undergoing treatment for skin cancer.
What Pharmacists Need to Know About Point-of-Care Testing for STIs
Pharmacists need a depth and breadth of knowledge to get the most out of point-of-care testing for sexually transmitted infections.
A Biosimilar Wave Looms Large Over US Biologics Market
As more adalimumab biosimilars are poised to enter the market, manufacturers, payers, and patient advocates are preparing to navigate potentially turbulent waters.
The JAK Inhibitor Pipeline Builds in Dermatology
Eight JAK inhibitors are approved by the FDA to treat autoimmune,
inflammatory, and allergic conditions.
Kudos to WHO
How Pharmacists Should Talk So Vaccine-Hesitant Parents Listen
Vaccine hesitancy exists on a spectrum, but with the right tools, pharmacists can provide education and reassurance to parents and caregivers.
National Pharmacy Chain Opioid Settlements Poised to Affect Independent Pharmacies
Stipulations of the settlements include data reporting, annual training, and an independent compliance officer.
Safety, Accuracy of Dexcom G7 CGM Evaluated in T1D and T2D
The CGM provides accurate readings over 10.5 days of continuous wear.
Thoughts From the Streets: The Rise of Xylazine in Illicit Drug Use
Rates of xylazine use have skyrocketed in since 2010, leading to an increase in overdoses and death.
FDA: Nerivio Cleared for Migraine Prevention
Nerivio received clearance in January 2021 for use in acute migraine.
The Cost of Keeping Proper Inventory
Keeping inventory always comes with various costs. How do pharmacies approach these obstacles?
Digital Therapies Poised for Breakthrough in Migraine Treatment
The number of digital therapeutics available for migraine is likely to expand.
2 Clarke Drive Cranbury, NJ 08512